CEPI to fund development of broadly protective betacoronavirus vaccines in India

The CEPI has partnered with an autonomous research institute of the Indian government and a Delhi-based biotech firm to develop vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.

Related Keywords

India ,Richard Hatchett ,Translational Health Science ,Technology Institute ,Department Of Biotechnology ,Ministry Of Science ,Coalition For Epidemic Preparedness Innovations ,Middle East ,Epidemic Preparedness Innovations ,Panacea Biotec ,Sars Cov 2 Variants ,Etacoronaviruses Coronaviruses ,Accine Dvelopment ,Accine Resarch ,Vaccine Funding , ,